Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of opioid-dependent adolescents and young adults with buprenorphine.
Subramaniam GA, Fishman MJ, Woody G. Subramaniam GA, et al. Curr Psychiatry Rep. 2009 Oct;11(5):360-3. doi: 10.1007/s11920-009-0054-5. Curr Psychiatry Rep. 2009. PMID: 19785976 Review.
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J. Lee JD, et al. Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14. Lancet. 2018. PMID: 29150198 Free PMC article. Clinical Trial.
Association of cannabis use with opioid outcomes among opioid-dependent youth.
Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD. Hill KP, et al. Drug Alcohol Depend. 2013 Sep 1;132(1-2):342-5. doi: 10.1016/j.drugalcdep.2013.02.030. Epub 2013 Mar 22. Drug Alcohol Depend. 2013. PMID: 23528523 Free PMC article. Clinical Trial.
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.
Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P. Woody GE, et al. JAMA. 2008 Nov 5;300(17):2003-11. doi: 10.1001/jama.2008.574. JAMA. 2008. PMID: 18984887 Free PMC article. Clinical Trial.
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.
Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Chakrabarti A, et al. Drug Alcohol Depend. 2010 Mar 1;107(2-3):253-6. doi: 10.1016/j.drugalcdep.2009.10.014. Epub 2009 Nov 30. Drug Alcohol Depend. 2010. PMID: 19948382 Free PMC article. Clinical Trial.
Beck Depression Inventory for depression screening in substance-abusing adolescents.
Subramaniam G, Harrell P, Huntley E, Tracy M. Subramaniam G, et al. J Subst Abuse Treat. 2009 Jul;37(1):25-31. doi: 10.1016/j.jsat.2008.09.008. Epub 2009 Mar 31. J Subst Abuse Treat. 2009. PMID: 19339144
Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility.
Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Fishman MJ, et al. Addiction. 2010 Sep;105(9):1669-76. doi: 10.1111/j.1360-0443.2010.03015.x. Epub 2010 Jul 9. Addiction. 2010. PMID: 20626723
Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.
John WS, Zhu H, Mannelli P, Subramaniam GA, Schwartz RP, McNeely J, Wu LT. John WS, et al. Among authors: subramaniam ga. Drug Alcohol Depend. 2019 Jan 1;194:468-475. doi: 10.1016/j.drugalcdep.2018.11.011. Epub 2018 Nov 26. Drug Alcohol Depend. 2019. PMID: 30513477 Free PMC article.
Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, Xu J, Thornton S, Tanney MR, Hawkins LA, Garvie PA, Subramaniam GA, Worrell CJ, Stoff LW; Adolescent Trials Network for HIVAIDS Interventions. Brown LK, et al. Among authors: subramaniam ga. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):38-46. doi: 10.1097/QAI.0000000000000803. J Acquir Immune Defic Syndr. 2016. PMID: 26761270 Free PMC article. Clinical Trial.
23 results
Jump to page
Feedback